Kavita Patel

Insider Reports History

Location
Waltham, MA
Signature
/s/ Daniel A. Boulware, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kavita Patel:

Company Role Class Num Shares Value Price $ Report Date Ownership
SelectQuote, Inc. Director Common Stock, par value $0.01 per share 363,214 $711,899 $1.96 11 Nov 2025 Direct
Arcellx, Inc. Director Common Stock 0 $0 $67.36 10 Jun 2025 Direct
SelectQuote, Inc. Director Restricted Stock Units 106,250 11 Nov 2025 Direct
Arcellx, Inc. Director Stock Option (right to buy) 27,077 10 Jun 2025 Direct
Sigilon Therapeutics, Inc. Director Stock Option (Right to Buy) 0 $0.7500 11 Aug 2023 Direct

Insider Reports Filed by Kavita Patel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SLQT SelectQuote, Inc. 11 Nov 2025 3 $0 4 Director 13 Nov 2025, 19:26
ACLX Arcellx, Inc. 10 Jun 2025 3 -$91,050 4 Director 11 Jun 2025, 17:37
ACLX Arcellx, Inc. 29 May 2025 1 $0 4 Director 30 May 2025, 16:20
ACLX Arcellx, Inc. 20 May 2025 3 -$77,655 4 Director 20 May 2025, 19:58
ACLX Arcellx, Inc. 29 Apr 2025 3 -$86,310 4 Director 29 Apr 2025, 18:34
ACLX Arcellx, Inc. 08 Apr 2025 3 -$76,260 4 Director 08 Apr 2025, 19:31
ACLX Arcellx, Inc. 18 Mar 2025 3 -$97,470 4 Director 18 Mar 2025, 19:01
ACLX Arcellx, Inc. 25 Feb 2025 3 -$84,750 4 Director 25 Feb 2025, 19:09
ACLX Arcellx, Inc. 04 Feb 2025 3 -$86,865 4 Director 04 Feb 2025, 21:17
ACLX Arcellx, Inc. 14 Jan 2025 5 -$88,811 4 Director 14 Jan 2025, 19:17
ACLX Arcellx, Inc. 24 Dec 2024 4 -$105,461 4 Director 26 Dec 2024, 20:42
ACLX Arcellx, Inc. 03 Dec 2024 7 -$127,828 4 Director 05 Dec 2024, 17:58
SLQT SelectQuote, Inc. 12 Nov 2024 3 $0 4 Director 14 Nov 2024, 20:57
ACLX Arcellx, Inc. 12 Nov 2024 3 -$149,505 4 Director 14 Nov 2024, 16:37
ACLX Arcellx, Inc. 07 Nov 2024 14 -$5,246,850 4 Director 12 Nov 2024, 20:30
ACLX Arcellx, Inc. 22 Oct 2024 3 -$124,545 4 Director 22 Oct 2024, 18:48
ACLX Arcellx, Inc. 01 Oct 2024 3 -$113,370 4 Director 03 Oct 2024, 16:00
ACLX Arcellx, Inc. 10 Sep 2024 3 -$101,625 4 Director 12 Sep 2024, 18:27
ACLX Arcellx, Inc. 20 Aug 2024 3 -$88,830 4 Director 22 Aug 2024, 16:01
ACLX Arcellx, Inc. 30 Jul 2024 4 -$82,959 4 Director 01 Aug 2024, 17:24
ACLX Arcellx, Inc. 09 Jul 2024 4 -$74,957 4 Director 11 Jul 2024, 16:04
ACLX Arcellx, Inc. 27 Jun 2024 4 -$476,056 4 Director 28 Jun 2024, 16:08
ACLX Arcellx, Inc. 28 May 2024 1 $0 4 Director 06 Jun 2024, 16:17
SLQT SelectQuote, Inc. 14 Nov 2023 3 $0 4 Director 16 Nov 2023, 19:44
/report/000141588923012130-patel-kavita-2023-08-11 Sigilon Therapeutics, Inc. 11 Aug 2023 2 -$7,952 4 Director 11 Aug 2023, 16:10
ACLX Arcellx, Inc. 14 Jun 2023 1 $0 4 Director 16 Jun 2023, 16:20
/report/000141588923008497-patel-kavita-2023-05-19 Sigilon Therapeutics, Inc. 19 May 2023 1 $0 4 Director 22 May 2023, 16:20
SLQT SelectQuote, Inc. 15 Nov 2022 3 $0 4 Director 17 Nov 2022, 17:49
/report/000141588922005828-patel-kavita-2022-05-26 Sigilon Therapeutics, Inc. 26 May 2022 1 $0 4 Director 27 May 2022, 17:01
ACLX Arcellx, Inc. 03 Feb 2022 1 $0 4 Director 07 Feb 2022, 17:02
ACLX Arcellx, Inc. 03 Feb 2022 0 $0 3 Director 03 Feb 2022, 16:31
SLQT SelectQuote, Inc. 09 Dec 2021 2 $0 4 Director 09 Dec 2021, 17:11
SLQT SelectQuote, Inc. 15 Nov 2021 1 $0 4 Director 15 Nov 2021, 20:18
/report/000110465921134634-patel-kavita-2021-11-04 Intelligent Medicine Acquisition Corp. 04 Nov 2021 0 $0 3 Director 04 Nov 2021, 21:26
/report/000141588921003239-patel-kavita-2021-06-24 Sigilon Therapeutics, Inc. 24 Jun 2021 1 +$88,613 4 Director 28 Jun 2021, 07:15